Bromocriptine mesylate: FDA-approved novel treatment for type-2 diabetes.

Suppr

超能文献

作者信息

Mahajan Rajiv

机构信息

Department of Pharmacology, AIMSR, Bhatinda, India. E-mail:

出版信息

Indian J Pharmacol. 2009 Aug;41(4):197-8. doi: 10.4103/0253-7613.56070.

DOI:10.4103/0253-7613.56070

PMID:20523873

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2875741/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4cd/2875741/bc169adaffbe/IJPharm-41-197-g001.jpg

相似文献

Bromocriptine mesylate: FDA-approved novel treatment for type-2 diabetes.

Indian J Pharmacol. 2009 Aug;41(4):197-8. doi: 10.4103/0253-7613.56070.

Use of prostaglandins and bromocriptine mesylate for pregnancy termination in bitches.

J Am Vet Med Assoc. 2002 Apr 1;220(7):1017-9. doi: 10.2460/javma.2002.220.1017.

Bromocriptine mesylate (Cycloset) for type 2 diabetes mellitus.

Am Fam Physician. 2013 May 15;87(10):718-20.

Successful treatment of a prolactin-producing pituitary macroadenoma with intravaginal bromocriptine mesylate: a novel approach to intolerance of oral therapy.

Obstet Gynecol. 1989 Mar;73(3 Pt 2):517-20.

Effect of Bromocriptine-QR (a Quick-Release Formulation of Bromocriptine Mesylate) on Major Adverse Cardiovascular Events in Type 2 Diabetes Subjects.

J Am Heart Assoc. 2015 Oct 16;4(10):e001991. doi: 10.1161/JAHA.115.001991.

Evaluation of a novel vaginal bromocriptine mesylate formulation: a pilot study.

Fertil Steril. 2005 Apr;83(4):1053-5. doi: 10.1016/j.fertnstert.2004.09.024.

Effect of bromocriptine mesylate on induced hyperprolactinemia in stabilized psychiatric outpatients undergoing neuroleptic treatment.

Neuropsychobiology. 1985;13(4):173-9. doi: 10.1159/000118184.

Color change in Perlodel tablets induced by LED lighting - photolysis of bromocriptine mesylate.

Pharmazie. 2019 May 1;74(5):286-289. doi: 10.1691/ph.2019.8109.

Focusing on cardiovascular disease in type 2 diabetes mellitus: an introduction to bromocriptine QR.

Postgrad Med. 2012 Sep;124(5):121-35. doi: 10.3810/pgm.2012.09.2598.

Bromocriptine mesylate (Parlodel) in the management of amenorrhea/galactorrhea associated with hyperprolactinemia.

Obstet Gynecol. 1980 Mar;55(3):278-84. doi: 10.1097/00006250-198003000-00002.

引用本文的文献

Biological mechanisms of dopamine D-like receptor agonist therapy in diabetes.

Front Endocrinol (Lausanne). 2025 Jan 20;16:1532414. doi: 10.3389/fendo.2025.1532414. eCollection 2025.

Efficacy and Safety of Bromocriptine-QR as an Adjunctive Therapy on Glycemic Control in Subjects with Uncontrolled Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis.

J ASEAN Fed Endocr Soc. 2024;39(1):95-105. doi: 10.15605/jafes.039.01.19. Epub 2024 Feb 21.

A Combination of a Dopamine Receptor 2 Agonist and a Kappa Opioid Receptor Antagonist Synergistically Reduces Weight in Diet-Induced Obese Rodents.

Nutrients. 2024 Jan 31;16(3):424. doi: 10.3390/nu16030424.

Dopamine 2 agonists for the management of type 2 diabetes: a systematic review and meta-analysis.

J Diabetes Metab Disord. 2023 May 12;22(2):931-943. doi: 10.1007/s40200-023-01230-4. eCollection 2023 Dec.

Optimization of Bromocriptine-Mesylate-Loaded Polycaprolactone Nanoparticles Coated with Chitosan for Nose-to-Brain Delivery: In Vitro and In Vivo Studies.

Polymers (Basel). 2023 Sep 26;15(19):3890. doi: 10.3390/polym15193890.

Subcutaneous adipose tissue dopamine D2 receptor is increased in prediabetes and T2D.

Endocrine. 2024 Feb;83(2):378-391. doi: 10.1007/s12020-023-03525-1. Epub 2023 Sep 26.

Inhibition of NLRP3 and Golph3 ameliorates diabetes-induced neuroinflammation and .

Aging (Albany NY). 2022 Nov 15;14(21):8745-8762. doi: 10.18632/aging.204363.

Circadian rhythms and pancreas physiology: A review.

Front Endocrinol (Lausanne). 2022 Aug 10;13:920261. doi: 10.3389/fendo.2022.920261. eCollection 2022.

Protective Role of Sarpogrelate in Combination with Bromocriptine and Cabergoline for Treatment of Diabetes in Alloxan-induced Diabetic Rats.

Curr Ther Res Clin Exp. 2021 Oct 12;95:100647. doi: 10.1016/j.curtheres.2021.100647. eCollection 2021.

Unravelling the utility of modern sulfonylureas from cardiovascular outcome trials and landmark trials: expert opinion from an international panel.

Indian Heart J. 2020 Jan-Feb;72(1):7-13. doi: 10.1016/j.ihj.2020.01.001. Epub 2020 Jan 13.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验